Aybo, Bb Boy .
HRN: 27-01-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/27/2025
05/04/2025
IV
45mg
Q12
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes